CINECA IRIS Institutional Research Information System

BASILE, Vittoria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.956
EU - Europa 1.449
AS - Asia 587
SA - Sud America 143
AF - Africa 33
OC - Oceania 27
Totale 4.195
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.889
IT - Italia 461
CN - Cina 222
DE - Germania 154
IE - Irlanda 126
JP - Giappone 119
FR - Francia 102
SE - Svezia 89
BR - Brasile 63
DK - Danimarca 57
ES - Italia 53
PL - Polonia 52
GB - Regno Unito 51
TR - Turchia 51
CA - Canada 44
UA - Ucraina 44
VN - Vietnam 43
AT - Austria 40
AR - Argentina 39
HU - Ungheria 35
IN - India 35
FI - Finlandia 30
RU - Federazione Russa 30
BE - Belgio 28
AU - Australia 25
KR - Corea 25
CH - Svizzera 19
CO - Colombia 19
MX - Messico 19
GR - Grecia 17
HK - Hong Kong 17
TW - Taiwan 16
DZ - Algeria 15
NL - Olanda 14
PT - Portogallo 14
SG - Singapore 13
IL - Israele 12
EC - Ecuador 7
MY - Malesia 6
PE - Perù 6
RS - Serbia 6
ZA - Sudafrica 6
CL - Cile 5
PH - Filippine 5
TH - Thailandia 5
BA - Bosnia-Erzegovina 4
HR - Croazia 4
JO - Giordania 4
SI - Slovenia 4
SY - Repubblica araba siriana 4
TN - Tunisia 4
VE - Venezuela 4
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
TZ - Tanzania 3
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
IR - Iran 2
KZ - Kazakistan 2
MA - Marocco 2
NO - Norvegia 2
SA - Arabia Saudita 2
SN - Senegal 2
UZ - Uzbekistan 2
BY - Bielorussia 1
FJ - Figi 1
ID - Indonesia 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
ME - Montenegro 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
Totale 4.195
Salva come PNG Salva come JPEG
Città #
Chandler 242
Ann Arbor 139
Fairfield 137
Dublin 122
Torino 91
Ashburn 87
Beijing 86
Woodbridge 79
Seattle 68
Cambridge 67
Redwood City 67
Wilmington 61
Houston 57
Nyköping 49
Jacksonville 42
Turin 41
Vienna 33
Medford 29
Princeton 27
Dong Ket 26
Würzburg 26
Shanghai 22
Villeurbanne 22
Okazaki 21
Munich 20
Pisa 20
Rochester 20
Budapest 19
Fremont 19
Dearborn 16
New York 16
Buenos Aires 15
Florence 15
Milan 15
Paris 15
Tokyo 14
Ankara 13
Taipei 13
Los Angeles 12
Moscow 12
Rio de Janeiro 12
Bogotá 11
Boston 11
Istanbul 11
Seoul 11
Warsaw 11
Chengdu 10
Rome 10
San Diego 10
Singapore 10
Szekszárd 10
Delhi 9
Fukuoka 9
Guangzhou 9
Zurich 9
Hangzhou 8
London 8
Portland 8
Uberlândia 8
Athens 7
Brescia 7
Brisbane 7
Brussels 7
Curitiba 7
Helsinki 7
Norwalk 7
Polska 7
Soliera 7
Amsterdam 6
Bad Zwischenahn 6
Barcelona 6
Bethesda 6
Bozeman 6
Gumyojicho 6
Lima 6
Logroño 6
Lublin 6
Matawan 6
Naples 6
Norfolk 6
Pasto 6
Alaşehir 5
Belgrade 5
Canberra 5
Durham 5
Florianópolis 5
Fürstenzell 5
General Rodriguez 5
Hamamatsu 5
Hefei 5
Heidelberg 5
Katowice 5
Liège 5
Longueuil 5
Madrid 5
Montréal 5
Nesher 5
Palermo 5
Riverton 5
Scott Depot 5
Totale 2.316
Salva come PNG Salva come JPEG
Nome #
New perspectives for mitotane treatment of adrenocortical carcinoma 952
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane. 403
18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma. 294
Aspetti medico legali e concetto di responsabilità in medicina d'emergenza - urgenza 254
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence. 253
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma 229
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 185
Diagnosi e terapia del carcinoma corticosurrenalico 171
Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study 157
Genetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 149
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 107
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 104
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options. 102
Mitotane concentrations influence outcome in patients with advanced adrenocortical carcinoma 94
Involvement of 27-Hydroxycholesterol in Mitotane Action on Adrenocortical Carcinoma 90
Mitotane: new facts for an old drug 88
Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study 87
Genetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 71
Unwanted hormonal and metabolic effects of postoperative adjuvant mitotane treatment for adrenocortical cancer 71
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane. 70
Genetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 59
SEX DIFFERENCES ON MITOTANE CONCENTRATION AND TREATMENT OUTCOME IN PATIENTS WITH ADRENOCORTICAL CARCINOMA 51
Sex Differences on Mitotane Concentration and Treatment Outcome in Patients with Adrenocortical Carcinoma 48
Oligometastatic adrenocortical carcinoma: the role of image-guided thermal ablation 41
What is the optimal duration of adjuvant mitotane therapy in adrenocortical carcinoma? An unanswered question 40
Sex-Based Evaluation of Lipid Profile in Postoperative Adjuvant Mitotane Treatment for Adrenocortical Carcinoma 27
Pregnancy in patients with adrenocortical carcinoma: a case-based discussion 23
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study 20
New findings on presentation and outcome of patients with adrenocortical cancer: results from a national cohort study 20
Sex differences on mitotane concentration and treatment outcome in patients with adrenocortical carcinoma 17
Gender-based evaluation of the effect of mitotane on total cholesterol, HDL, LDL and triglycerides levels in patients with adrenocortical carcinoma 17
Gender-based evaluation of the effect of mitotane on total cholesterol, HDL, LDL and triglycerides levels in patients with adrenocortical carcinoma 15
The management of post-operative disease recurrence in patients with adrenocortical carcinoma: a retrospective study in 106 patients 12
Gender-based evaluation of the effect of mitotane on total cholesterol, HDL, LDL and triglycerides levels in patients with adrenocortical carcinoma 12
Adrenal cortical carcinoma: mitotane and beyond 10
The Value of Local Therapies in Advanced Adrenocortical Carcinoma 2
Totale 4.345
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.781
article - articoli 0
book - libri 0
conference - conferenze 1.476
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.257
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201998 0 0 0 0 0 0 0 0 0 22 50 26
2019/2020443 19 17 16 39 25 54 28 47 66 48 37 47
2020/2021699 59 35 63 37 43 43 47 54 39 70 101 108
2021/2022914 74 50 58 76 82 65 67 68 62 88 130 94
2022/20231.083 92 107 50 86 80 176 66 82 125 47 85 87
2023/2024717 86 125 62 85 83 76 47 76 28 49 0 0
Totale 4.345